Viewing Study NCT00927602


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-06-26 @ 4:59 AM
Study NCT ID: NCT00927602
Status: TERMINATED
Last Update Posted: 2012-04-24
First Post: 2009-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
Sponsor: Università degli Studi dell'Insubria
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2008-005234-79
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators